Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Private Banking: Between High Figures and Hard Questions

Private Banking: Between High Figures and Hard Questions

Biosimilar push: Dr Reddy’s gets EU nod for denosumab copy; Prolia, Xgeva rivals set for rollout

Biosimilar push: Dr Reddy’s gets EU nod for denosumab copy; Prolia, Xgeva rivals set for rollout

2025 vs 2024 – UK Broadband and Mobile Speeds vs the World

2025 vs 2024 – UK Broadband and Mobile Speeds vs the World

Hanoi’s focus must shift to implementation of Vietnam-EFTA FTA: Study

Hanoi’s focus must shift to implementation of Vietnam-EFTA FTA: Study

Hyderadbad-based Dr Reddy’s gets European approval for osteoporosis biosimilar AVT03

Hyderadbad-based Dr Reddy’s gets European approval for osteoporosis biosimilar AVT03

All the new border laws in 2026 for people travelling to and from the UK

All the new border laws in 2026 for people travelling to and from the UK

Dr. Reddy's receives European Commission Approval for AVT03 (denosumab), a Proposed Biosimilar of Prolia® and Xgeva®

Dr. Reddy's receives European Commission Approval for AVT03 (denosumab), a Proposed Biosimilar of Prolia® and Xgeva®

Dr Reddy’s gets marketing authorisation for biosimilar from European Commission

Dr Reddy’s gets marketing authorisation for biosimilar from European Commission

Dr Reddy’s gets EC nod for AVT03: New Prolia and Xgeva biosimilar set to launch across Europe

Dr Reddy’s gets EC nod for AVT03: New Prolia and Xgeva biosimilar set to launch across Europe

Dr Reddy's gets European nod for biosimilar to treat osteoporosis

Dr Reddy's gets European nod for biosimilar to treat osteoporosis

The overlooked European country you can hike across in just three days

The overlooked European country you can hike across in just three days

US lands framework trade deals with Switzerland, 5 other trading partners

US lands framework trade deals with Switzerland, 5 other trading partners

UAE welcomes statements by US Secretary of State on cessation of Sudan hostilities

UAE welcomes statements by US Secretary of State on cessation of Sudan hostilities

India leverages free trade agreements to attract foreign investment

India leverages free trade agreements to attract foreign investment

India Forges New Trade Ties In 2025 To Hedge Against Global Uncertainties

India Forges New Trade Ties In 2025 To Hedge Against Global Uncertainties

Ondo turns to Figure’s stablecoin with $25M investment to back tokenized fund

Ondo turns to Figure’s stablecoin with $25M investment to back tokenized fund

New Zealand-India FTA: No built in grace period for NZ to meet its $20 billion investment commitment

New Zealand-India FTA: No built in grace period for NZ to meet its $20 billion investment commitment

The year in patriarchy: Taylor Swift’s engagement, Trump 2.0 and the Epstein files

The year in patriarchy: Taylor Swift’s engagement, Trump 2.0 and the Epstein files

Oil set for second weekly drop on potential Russia-Ukraine peace deal

Oil set for second weekly drop on potential Russia-Ukraine peace deal

The 87 most eligible bachelors in Britain...and it helps to be a nepo baby! Tatler's list of the most desirable men under 35 is a roll call of socialites, sports stars and even a Spice Girl's son

The 87 most eligible bachelors in Britain...and it helps to be a nepo baby! Tatler's list of the most desirable men under 35 is a roll call of socialites, sports stars and even a Spice Girl's son

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions